Literature DB >> 9737663

Origin and properties of soluble CD21 (CR2) in human blood.

N R Ling1, D L Hardie, G D Johnson, I C MacLennan.   

Abstract

By analysis with a panel of CD21 MoAbs it is shown that a large part of the soluble CD21 in human blood plasma is of the long isoform (CD21L), as judged by comparison with antigen produced by mouse L cells transfected with CD21L-cDNA and reactivity with the restricted CD21 MoAb R4/23. This is compatible with the hypothesis that soluble CD21 in the blood is mainly derived from follicular dendritic cells (FDC). Cells from a human keratinocyte cell line transfected with cDNA from the Burkitt lymphoma cell line Raji also produced soluble CD21L (sCD21L), whereas the short form of sCD21 (sCD21S) was the major component of sCD21 produced by the B lymphoblastoid cell line LICR-LON-HMy and the T cell line Jurkat. Confocal studies of FDC isolated from human tonsil revealed that CD21 was present in the cytoplasm. On gel filtration sCD21 from untreated serum has an apparent size considerably greater than the 130kD found by SDS-PAGE analysis. This may be partly accounted for by the non-globular shape of the molecule, but may also indicate, as reported by others, that in its native state sCD21 is complexed with other proteins. However, no evidence of complexing with sCD23 or C3d could be found.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9737663      PMCID: PMC1905057          DOI: 10.1046/j.1365-2249.1998.00668.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  22 in total

1.  Soluble forms of CD21 and CD23 antigens in the serum in B cell chronic lymphocytic leukaemia.

Authors:  J Lowe; B Brown; D Hardie; P Richardson; N Ling
Journal:  Immunol Lett       Date:  1989-01-31       Impact factor: 3.685

2.  A novel mechanism of alternative pathway complement activation accounts for the deposition of C3 fragments on CR2-expressing homologous cells.

Authors:  M G Schwendinger; M Spruth; J Schoch; M P Dierich; W M Prodinger
Journal:  J Immunol       Date:  1997-06-01       Impact factor: 5.422

3.  Variability of CR2 gene products is due to alternative exon usage and different CR2 alleles.

Authors:  L E Toothaker; A J Henjes; J J Weis
Journal:  J Immunol       Date:  1989-05-15       Impact factor: 5.422

4.  Purification of the B lymphocyte receptor for the C3d fragment of complement and the Epstein-Barr virus by monoclonal antibody affinity chromatography, and assessment of its functional capacities.

Authors:  J J Weis; S A Richards; J A Smith; D T Fearon
Journal:  J Immunol Methods       Date:  1986-08-21       Impact factor: 2.303

5.  Human follicular dendritic cells (FDC): a study with monoclonal antibodies (MoAb).

Authors:  G D Johnson; D L Hardie; N R Ling; I C Maclennan
Journal:  Clin Exp Immunol       Date:  1986-04       Impact factor: 4.330

6.  Expression of CR2/EBV receptors on human thymocytes detected by monoclonal antibodies.

Authors:  C D Tsoukas; J D Lambris
Journal:  Eur J Immunol       Date:  1988-08       Impact factor: 5.532

7.  Human marginal zone B cells are not an activated B cell subset: strong expression of CD21 as a putative mediator for rapid B cell activation.

Authors:  W Timens; A Boes; S Poppema
Journal:  Eur J Immunol       Date:  1989-11       Impact factor: 5.532

8.  Soluble recombinant CR2 (CD21) inhibits Epstein-Barr virus infection.

Authors:  G R Nemerow; J J Mullen; P W Dickson; N R Cooper
Journal:  J Virol       Date:  1990-03       Impact factor: 5.103

9.  Production of a monoclonal antibody reactive with human dendritic reticulum cells and its use in the immunohistological analysis of lymphoid tissue.

Authors:  M Naiem; J Gerdes; Z Abdulaziz; H Stein; D Y Mason
Journal:  J Clin Pathol       Date:  1983-02       Impact factor: 3.411

10.  Mapping of the Epstein-Barr virus and C3dg binding sites to a common domain on complement receptor type 2.

Authors:  C A Lowell; L B Klickstein; R H Carter; J A Mitchell; D T Fearon; J M Ahearn
Journal:  J Exp Med       Date:  1989-12-01       Impact factor: 14.307

View more
  2 in total

1.  Dissociation of HIV-1 from follicular dendritic cells during HAART: mathematical analysis.

Authors:  W S Hlavacek; C Wofsy; A S Perelson
Journal:  Proc Natl Acad Sci U S A       Date:  1999-12-21       Impact factor: 11.205

2.  Enhanced CD21 expression and shedding in chronic lymphatic leukemia: a possible pathomechanism in disease progression.

Authors:  Hui Zhi Low; Dorothee Hilbrans; Ingo G H Schmidt-Wolf; Harald Illges
Journal:  Int J Hematol       Date:  2012-08-17       Impact factor: 2.490

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.